Sustainability Professional skill highlights: lab facility planning and fit out, lab operations management, project management, document management (QMS), budgeting, procurement, safety program management and technical training. Worldwide, News & This area provides news, videos and publications, as well as overviews of social Media channels and mobile apps of the Bayer Group. NextPoint Therapeutics has announced an $80 million Series B funding round to move two lead precision immuno-oncology programs into the clinic. Furthermore, where permissible, we may charge for this service. NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. (DE), Bayer any facility of a national securities exchange of the United States and the tender offer cannot be The Bayer brand stands for trust, reliability and quality throughout the world. Join to view profile NextPoint Therapeutics, Inc. . of Biodiversity, Modern 24. CAMBRIDGE, Mass. +49 214 30 1, Mllerstrae 178 Describe your request with sufficient detail that allows us to properly understand, evaluate, and respond to it. Protection Products & Seeds, Supplier As part of the financing, Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, and Paulina Hill, Partner at Sanofi Ventures, will join the NextPoint Board of Directors. Australia, Canada or Japan or any other jurisdiction, where access to the materials is prohibited or 50 Positions, Protection NextPoint Therapeutics - Crunchbase Company Profile & Funding A spokesperson for Boston-based NextPoint declined . Making press announcements and other documents Individuals in California, the EU and certain other jurisdictions who are accessing this site and whose data we may be collecting and processing may have certain rights under applicable data protection law, including the right to request confirmation from us as to whether or not we are processing your Personal Data. Global Product Strategy, Position & Science, Business For more information, go to www.bayer.com. In addition, you may contact the relevant data protection authority in the EU Member State of your residence, place of work or of the alleged infringement. join By using any portion of the Site, you acknowledge and consent to the transfer of your information to our facilities in the United States. NextPoint does not sell your Personal Information. Archive, Quarterly jurisdictions. As CMO, Dr. Gandhi will oversee the clinical development of NextPoints precision immuno-oncology programs that target the newly discovered HHLA2 pathway to activate anti-tumor immune responses. Leena Gandhi, director of the Dana-Farber Cancer Institute's Center for Cancer Therapeutic Innovation and a 15-year veteran of the organization, has left to become chief medical officer of. Digital in Warsaw, Bayer INFORMATION FROM CHILDREN UNDER 13 YEARS OF AGE. Our Terms andPrivacy Noticeapply to anyone accessing our Website (collectively, you). Jan 10, 2023. www.precisiononcologynews.com . Authority, United Arab NextPoint Therapeutics is an exciting early-stage Boston-area startup company working at the frontier of immuno-oncology. At the same time, the Group aims to increase its earning power and create value through innovation and growth. We encourage you to review this Privacy Notice often to stay informed of how we may process your information. Reporting to the Chief Medical Officer, the Vice President will build our Translational Medicine capability, responsible for managing research activities bridging from discovery to clinical development. of, Palestinian Innovation, Bayer Existing investors that took part in the financing include MPM Capital Management, Dana-Farber Cancer Institutes Binney Street Capital and NextPoint founder Gordon Freeman, PhD. & LEVERKUSEN, Germany, January 10, 2023--NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Community, Bayer Disseminate materials that impact or invade the privacy of others, such as photographs, video clips, sound recordings, personally identifiable information, or other materials that reveal personal, private or sensitive information about another person, without that persons consent. Degree in nursing, life sciences or a related discipline preferred. 10+ years of pharmaceutical or biotechnology industry experience or mix of industry and academic experience in oncology or cancer immunotherapy with an emphasis on translational research, clinical biomarkers, and monoclonal antibodies, Proven track record of transitioning biomarkers from the bench to the clinic, Strong knowledge of immuno-oncology and associated biomarker approaches, Technical expertise in IHC, RNAscope, flow cytometry, genetics (including ctDNA), RNA-Seq, NanoString, qPCR and ELISAs, Proven success with filing INDs and supporting clinical trials, Competency with bioinformatic datasets and experience collaborating with bioinformaticians to analyze publicly available datasets, Excellent communication and interpersonal skills, personal integrity, professional manner, and ability to gain respect and develop good working relationships with cross functional personnel at all levels, Ability to balance multiple stakeholders and projects simultaneously, and able to operate with high accountability and under tight deadlines, Forward looking thinker, who actively seeks opportunities and proposes solutions with strong decision-making capability, A collaborator who communicates in an open, clear, complete, timely and consistent manner who listens effectively and invites response and discussion, Direct and run clinical operations and clinical trial launch activities for clinical programs, Manage clinical research organizations, clinical and testing lab vendors, Establish clinical operations infrastructure across the organization, Maintain relationships with Sites and KOLs, Represent NextPoint at Scientific and Investigator Meetings, Stay apprised of current trends in clinical trials research and regulatory landscape, Take responsibility for launch and day-to-day operational management of clinical trials including study sites, Participate in Clinical Vendor Governance and Safety Review Committee Meetings, Design and perform ligand binding assays in multi-well formats to analyze novel antibody therapeutics, Develop and execute functional assays involving primary human immune cells, mammalian cell culture, and multi-color flow cytometry to screen novel antibody therapeutics in an immune-oncology setting, Work independently to design and conduct experiments, analyze, interpret, and communicate data in team meetings and to leadership, Support the laboratory organization and operations by maintaining lab equipment and managing reagent and supply inventories, Bachelors degree in cell/molecular biology, immunology, or cancer biology or equivalent field, 2 + years hands-on experience in drug discovery research preferably in an industry setting, Experience with cell-based functional immune assays such as MLR, immune cell activity assays, and cytokine release assays, Experience with multiparameter flow cytometry, Hands on experience with murine tumor models preferred, Excellent verbal and written communication skills with a demonstrated ability to work collaboratively and thrive in a team environment, Excellent interpersonal skills and willingness to learn a variety of new techniques and technologies; flexibility to adapt to rapidly changing priorities and deadlines. Development Policy, Corporate As a leader in healthcare, Bayer provides innovative While immune checkpoint inhibitors targeting PD-1/L1 have revolutionized cancer treatments, many patients do not benefit from these medications and require novel therapeutic strategies. be NextPoint originated from the combined expertise of its academic founders, Gordon Freeman, PhD, of the Dana-Farber Cancer Institute, and XingXing Zang, PhD, of Albert Einstein College of Medicine. For the purposes of this provision, the expression an offer to the public in relation to any NextPoint Therapeutics Raises $80M in Series B Financing Jan 10, 2023| staff reporter Save for later NEW YORK - NextPoint Therapeutics said on Tuesday that it has raised $80 million in Series B financing, which it will put toward advancing its precision oncology drugs targeting the HHLA2 pathway. NextPoints approach re-activates immune cells in tumors that are suppressed by HHLA2-driven immune evasion. Oricell Therapeutics was founded in 2015 as an innovative biopharmaceutical company in China. NextPoint is building a deep understanding of the HHLA2 tumor-specific immune-escape mechanism, with the ultimate goal of establishing standalone treatments in cancers with high HHLA2 expression, said Detlev Biniszkiewicz, PhD, Chief Executive Officer of NextPoint Therapeutics. restricted. Stock Market | Finance Our innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Rica, Czech Phone: Drs. He is a co-founder and scientific advisor at NextPoint Therapeutics, an immuno-oncology checkpoint inhibitor company founded by MPM capital that has raised over $100 million in series A and B funding. Zealand, Palestinian or subscribe for, any securities. Management, Supervisory Secret of the Bridge, Rice We'd love to talk to you. NextPoint Therapeutics develops medications to expand the benefit of immunotherapies to cancer patients. Joash Tan - Regional Medical Affairs Associate (APAC) - LinkedIn At Regulus Therapeutics, he led the fibrosis and the platform groups that contributed to advancing multiple microRNA-based programs into the clinic. 2 Bhatt RS, Berjis A, Konge JC, et al. the securities prospectus. Bachelor of Science required, Masters of Science preferred. Sterling National Bank is providing $2.5 million in a senior facility, and Bigfoot Capital is providing $2.0m in mezzanine financing. Results, AGM 5+ years experience leading cross-functional team operations including direct clinical trial management. offer or agreement to subscribe, purchase or otherwise acquire such securities will be engaged in Applicants for the VP, Translational Science should reach out to Ashleigh Cunningham, acunningham@kleinhersh.comour staffing partner atKlein Hersh. China, United About BayerBayer is a global enterprise with core competencies in the life science fields of health care and nutrition. State. Water